Roxanne Desiderio

Appearances

ASSOCIATION OF GLUCAGON-LIKE PEPTIDE-1 AGONISTS WITH CIRRHOSIS AND HEPATOCELLULAR CANCER IN METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
Date
May 18, 2024
BACKGROUND: Patients with MASLD and diabetes have an increased risk of cirrhosis and hepatocellular cancer (HCC). Recent studies show that glucagon-like peptide-1 (GLP-1) agonists, such as semaglutide, are effective in improving liver inflammation in MASLD…
Presenter
Fasiha Kanwal
Michael E. DeBakey VAMC
Speakers
Jennifer Kramer
Liang Li
Yumei Cao
Yu-Xiao Yang
The Perelman School of Medicine at the University of Pennsylvania
Xian Yu
Ronald Samuel
Basim Ali
Roxanne Desiderio
George Cholankeril
Steven Asch
Hashem El-Serag
Baylor College of Medicine